Onn Min Kon
Imperial College Healthcare
255 Papers
1.1K Citations
Onn Min Kon is an academic researcher from Imperial College Healthcare. The author has contributed to research in topics: Medicine & Tuberculosis. The author has an hindex of 51, co-authored 227 publications. Previous affiliations of Onn Min Kon include National Institute for Health Research & National Institute for Medical Research.
Chat about Author
Papers
Evaluation of screening methods for identification of patients with chronic rheumatological disease requiring tuberculosis chemoprophylaxis prior to commencement of TNF-α antagonist therapy
Aran Singanayagam,Kavina Manalan,Saranya Sridhar,Philip L. Molyneaux,D W Connell,Peter M. George,Anne Kindelerer,Suranjith L. Seneviratne,Ajit Lalvani,M Wickremasinghe,Onn Min Kon +10 more
TL;DR: The results suggest that use of all three screening modalities gives the highest yield of patients potentially requiring chemoprophylaxis, which was greater than any single test or two-test combination.
28
Viral hepatitis prevalence in patients with active and latent tuberculosis.
Hesam Ahmadi Nooredinvand,D W Connell,Mahmoud Asgheddi,Mohammed M. Ba Abdullah,M O’Donoghue,Louise Campbell,M Wickremasinghe,Ajit Lalvani,Onn Min Kon,Shahid A. Khan +9 more
TL;DR: Viral hepatitis screening should be considered in TB patients and DILI risk was not increased in patients with HBV/HCV, significantly higher than the estimated United Kingdom prevalence.
Diabetes mellitus and latent tuberculosis infection: baseline analysis of a large UK cohort
Charlotte Jackson,Jo Southern,Ajit Lalvani,Francis Drobniewski,Chris Griffiths,Marc Lipman,Graham H. Bothamley,Jonathan J Deeks,Jonathan J Deeks,Ambreen Imran,Onn Min Kon,Sithembinkosi Mpofu,Vladyslav Nikolayevskyy,Melanie Rees-Roberts,Alice J Sitch,Saranya Sridhar,CY Tsou,Hilary S. Whitworth,Ibrahim Abubakar +18 more
TL;DR: A cross-sectional analysis of baseline data from a UK cohort study which enrolled participants at risk of latent tuberculosis infection (LTBI) found that DM was associated with a 15% higher prevalence of LTBI.
27
An update on multidrug-resistant tuberculosis
TL;DR: Treatment of MDR-TB remains a challenge as it relies on prolonged second-line drug treatments that are less effective and more toxic than first-line treatments, and two new drug treatments have been approved; bedaquiline and delamanid.
Primary nodal anthracosis identified by EBUS-TBNA as a cause of FDG PET/CT positive mediastinal lymphadenopathy
Richard J. Hewitt,Corrina Wright,David Adeboyeku,Dan Ornadel,Matthew Berry,Melissa Wickremasinghe,Andrew Wright,Annemarie Sykes,Onn Min Kon,Onn Min Kon +9 more
TL;DR: Five cases of mediastinal lymphadenopathy are presented here in which lymph node anthracosis was identified as the primary diagnosis using EBUS-TBNA, and it is likely that primary nodal Anthracosis will be encountered more frequently and should be considered in the differential diagnosis of those with PET/CT positive lymphadenopathies.
27